Medical News

RSS

St. Jude Medical opens first Advanced Learning Center in Brussels

St. Jude Medical, Inc. (NYSE:STJ) today announced the official opening of the St. Jude Medical Advanced Learning Center, in Brussels, Belgium, offering education and training in advanced, evidence-based therapies for physicians who treat heart disease.

28 Aug 2009

NAT gains importance as traditional testing methods become inadequate

An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).

28 Aug 2009

ASHG 2009 Annual Meeting to discuss the cutting-edge developments in human genetics and genomics research

The world's top scientists and clinicians in the human genetics field will gather in Honolulu, Hawaii to present their latest research findings at the 59th Annual Meeting of the American Society of Human Genetics, from Tuesday, October 20, through Saturday, October 24, 2009, at the Hawaii Convention Center.

28 Aug 2009

Involving nursing staffs in the assessment and application of healthcare technologies helps VCU Medical Center to improve workflow efficiency

InnerWireless®, Inc., the premier provider of end-to-end in-building converged wireless solutions, today reported that Spyglass Consulting Group’s independent study of the new Critical Care Hospital at Virginia Commonwealth University Medical Center (VCU Medical Center) reveals the benefits of involving nursing staffs in the assessment and application of healthcare technologies such as InnerWireless’ Horizon™ Converged Wireless solution.

28 Aug 2009

Research study associates KIAA0319 gene on Chromosome 6 with variability in language abilities

A new candidate gene for Specific Language Impairment (SLI) has been identified by a research team directed by Mabel Rice from the University of Kansas, in collaboration with Shelley Smith, University of Nebraska Medical Center, and Javier Gayán of Neocodex, Seville, Spain.

28 Aug 2009

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

QRS duration (QRSd) is one of several measures of heart function recorded during a routine electrocardiogram (ECG). It is a composite of waves showing the length of time it takes for an electrical signal to get all the way through the pumping chambers of the heart. Prolonged QRSd is a sign of an abnormal electrical system of the heart and is often found when the heart isn't pumping efficiently.

28 Aug 2009

Nurse practitioners and physician assistants may help with primary care shortage

Nurse practitioners and physician assistants may help mitigate the primary care physician shortage.

28 Aug 2009

ReBuilder Medical Technologies reports 100% increase in second-quarter 2009 profits over first-quarter

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has published its second quarter 09 profits and that profits are up 100% over the first quarter.

28 Aug 2009

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.

28 Aug 2009

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.

28 Aug 2009

Study on basic mechanisms that control fertility in worms may help to know how some woman regain their fertility after cancer treatment

Scientific dogma has long asserted that females are born with their entire lifetime's supply of eggs, and once they're gone, they're gone. New findings by researchers at Fred Hutchinson Cancer Research Center, published online Aug. 27 in Science, suggest that in nematode worms, at least, this does not hold true.

28 Aug 2009

WERF to assess the hidden cost of endometriosis to society and women with the disease

The World Endometriosis Research Foundation (WERF) has raised sufficient funds to commence the first ever prospective study to assess the hidden cost of endometriosis to society and to women with the disease.

28 Aug 2009

Albert Einstein College of Medicine receives $11.2 million NIH grant to study genes associated with longevity

The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.

28 Aug 2009

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Measuring circulation in the ankle using a device similar to a blood pressure cuff can help identify asymptomatic peripheral artery disease (PAD) in stroke and transient ischemic attack (TIA) survivors, a group at much higher risk of subsequent cerebrovascular events, according to a study in Stroke: Journal of the American Heart Association.

28 Aug 2009

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.

28 Aug 2009

Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched fluconazole injection in premix bags. IMS Health estimates that 2008 U.S. sales of fluconazole injection approximated $18 million. Sagent will begin marketing and shipping fluconazole bags immediately.

28 Aug 2009

Study reveals the mechanisms of sodium tungstate in treating diabetes

The molecular mechanisms of tungstate activity in diabetes have been uncovered. Researchers writing in the open access journal BMC Genomics have identified the pathways through which sodium tungstate improves pancreatic function and beta cell proliferation.

28 Aug 2009

MoBx Mobile Breast Services acquired by United Medical Systems

United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS’ stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.

28 Aug 2009

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, have received a Phase I Small Business Technology Transfer (STTR) contract in the amount of $100,000 to support research to identify lead antimicrobial compounds to effectively treat multi-drug resistant and biofilm-embedded bacteria.

28 Aug 2009

Enzymes could be targeted to kill dangerous pathogens

Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.

28 Aug 2009

Medical News

St. Jude Medical opens first Advanced Learning Center in Brussels

NAT gains importance as traditional testing methods become inadequate

ASHG 2009 Annual Meeting to discuss the cutting-edge developments in human genetics and genomics research

Involving nursing staffs in the assessment and application of healthcare technologies helps VCU Medical Center to improve workflow efficiency

Research study associates KIAA0319 gene on Chromosome 6 with variability in language abilities

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

Nurse practitioners and physician assistants may help with primary care shortage

ReBuilder Medical Technologies reports 100% increase in second-quarter 2009 profits over first-quarter

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Study on basic mechanisms that control fertility in worms may help to know how some woman regain their fertility after cancer treatment

WERF to assess the hidden cost of endometriosis to society and women with the disease

Albert Einstein College of Medicine receives $11.2 million NIH grant to study genes associated with longevity

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags

Study reveals the mechanisms of sodium tungstate in treating diabetes

MoBx Mobile Breast Services acquired by United Medical Systems

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

Enzymes could be targeted to kill dangerous pathogens

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News